Stablepoint Partners LLC lowered its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 7.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 12,702 shares of the company’s stock after selling 1,000 shares during the quarter. Stablepoint Partners LLC’s holdings in BlackRock Health Sciences Term Trust were worth $183,000 at the end of the most recent reporting period.
Several other hedge funds have also recently modified their holdings of BMEZ. Brown Brothers Harriman & Co. bought a new stake in BlackRock Health Sciences Term Trust in the 3rd quarter worth approximately $32,000. K2 Principal Fund L.P. bought a new stake in BlackRock Health Sciences Term Trust in the third quarter worth $158,000. Jane Street Group LLC purchased a new stake in BlackRock Health Sciences Term Trust during the third quarter valued at $357,000. Dakota Wealth Management lifted its position in BlackRock Health Sciences Term Trust by 23.4% during the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares during the last quarter. Finally, Brown Lisle Cummings Inc. grew its stake in shares of BlackRock Health Sciences Term Trust by 6.2% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock worth $578,000 after buying an additional 2,128 shares in the last quarter.
BlackRock Health Sciences Term Trust Stock Performance
BlackRock Health Sciences Term Trust stock opened at $16.39 on Monday. BlackRock Health Sciences Term Trust has a twelve month low of $14.27 and a twelve month high of $16.59. The company’s 50-day moving average price is $15.29 and its 200-day moving average price is $15.61.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- How to Use the MarketBeat Dividend Calculator
- MP Materials: Rare Earth Elements Powering the EV Boom
- Retail Stocks Investing, Explained
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Bloom Energy: Powering the Future With Decentralized Energy
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.